WCH26: Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors
Released on
January 8, 2026
WCH26: Checkpoint Choices in Cutaneous Squamous Cell Carcinoma (cSCC): Case-Based Exploration of the Role of PD-1 and New PD-L1 Inhibitors
This activity is supported by an educational grant from Sun Pharmaceutical Industries Ltd.